Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation

SIMPLE SUMMARY: Personalized therapy of non-small cell lung cancer (NSCLC) relies heavily on histopathological analyses that require invasive biopsies that have relatively high costs, provide limited assessment of tumor heterogeneity and are associated with potentially life-threatening complications...

Descripción completa

Detalles Bibliográficos
Autores principales: Luna, José Marcio, Barsky, Andrew R., Shinohara, Russell T., Roshkovan, Leonid, Hershman, Michelle, Dreyfuss, Alexandra D., Horng, Hannah, Lou, Carolyn, Noël, Peter B., Cengel, Keith A., Katz, Sharyn, Diffenderfer, Eric S., Kontos, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833400/
https://www.ncbi.nlm.nih.gov/pubmed/35158971
http://dx.doi.org/10.3390/cancers14030700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833400/
https://www.ncbi.nlm.nih.gov/pubmed/35158971
http://dx.doi.org/10.3390/cancers14030700

Ejemplares similares